Home Qynapse

Qynapse

Qynapse

Qynapse
Category
Business Description
The future of neuroimaging analysis is here and Qynapse is leading the way. For clinicians on the front lines, for patients and their families, for payers, and for pharma – we offer peace of mind by providing results you can trust. We are constantly evolving, refining and testing our FDA-cleared and CE-marked neuroimaging software platform, QyScore®, which is powered by proprietary Artificial Intelligence, to provide physicians, pharma researchers and payers a reliable layer of precision when reading an MRI scan. QyPredict®, our predictive research-use-only platform powered by machine learning algorithms, is being designed to transform what we know about CNS disease trajectory, with the potential to dramatically increase the likelihood of a successful clinical trial.
Based in
Paris
Tags
Artificial Intelligence, Clinical Trials, Health Care, Information Technology, Machine Learning, Medical, Neuroscience, Software
Total Funding
Between €5 million-€10 million
Founded
2015
Website
http://www.qynapse.com/

Articles about Qynapse:

💡 You're a corporate or investor and looking for startups that are innovating in the same market as Qynapse? We're happy to assist you with our Startup Sourcing service.